Cas:342-52-9 N-(2-fluoro-6-nitrophenyl)acetamide manufacturer & supplier

We serve Chemical Name:N-(2-fluoro-6-nitrophenyl)acetamide CAS:342-52-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N-(2-fluoro-6-nitrophenyl)acetamide

Chemical Name:N-(2-fluoro-6-nitrophenyl)acetamide
CAS.NO:342-52-9
Synonyms:2-Fluor-6-nitro-acetanilid;acetic acid-(2-fluoro-6-nitro-anilide);N-(6-fluoro-2-nitrophenyl)acetamide;Essigsaeure-(2-fluor-6-nitro-anilid);N-(2-fluoro-6-nitrophenyl) acetamide
Molecular Formula:C8H7FN2O3
Molecular Weight:198.15100
HS Code:2924299090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:371.2ºC at 760 mmHg
Density:1.429g/cm3
Index of Refraction:1.594
PSA:74.92000
Exact Mass:198.04400
LogP:2.28850

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-Fluor-6-nitro-acetanilid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-(2-fluoro-6-nitrophenyl) acetamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-(6-fluoro-2-nitrophenyl)acetamide Use and application,Essigsaeure-(2-fluor-6-nitro-anilid) technical grade,usp/ep/jp grade.


Related News: The government has approved a total of 33 applications with a committed investment of Rs 5,082.65 crore under the production linked incentive scheme for active pharmaceutical ingredients, an official release said on Thursday. dicyclopentyl (R,R)-tartrate manufacturers Enzymes play a pivotal role in the catalysis of many different bio-transformation reactions in nature, typically exerting their effects under mild, neutral conditions. Monothiophosphorsaeure-O,O-diethyl-S-butylmercaptomethyl-ester suppliers The government has approved a total of 33 applications with a committed investment of Rs 5,082.65 crore under the production linked incentive scheme for active pharmaceutical ingredients, an official release said on Thursday. N’,N’,N”-Tri-(N-hydroxyberberinylethylamide) of thiophosphoric acid vendor & factory EMA’s human medicines committee (CHMP) has endorsed findings of a review which concluded that there is no evidence Zynteglo causes a blood cancer known as acute myeloid leukaemia (AML).,“The approval of Verquvo in the EU will provide doctors, health care professionals and patients with an important treatment option to complement currently available heart failure therapies,” he added.